• Home
  • Radiation Oncology

Radiation Oncology

Radiation Oncology

Overview

The mission of the Radiation Oncology department (including Cancer Research Institute) is to provide compassionate, state-of-the-art, quality radiation treatment to cancer patients integrating education, clinical research, and radiation physics.  The department focuses on both, conventional and cutting-edge techniques.

The department is the most comprehensive facility of its kind in the state of Uttarakhand. Board-certified radiation oncologists are skilled in a wide range of standard and emerging treatments which are continuously refined to deliver the highest-quality patient care possible. Our range of equipment & treatment strategies include latest techniques to treat tumours, ensuring that tumours get the most effective dose while healthy tissues & organs are spared even as some of the side-effects that accompany radiation (treatment) are reduced / eliminated.

The Radiation Oncology Department is equipped with two LINACs with facilities of Photon Beam, Electron Beam, 3D-CRT, IMRT along with latest brachytherapy Technologies. Department has Indoor wards for   diagnosis of cancer, chemotherapy, concomitant chemoradiotherapy, supportive care and oncology emergencies. 

Besides the teaching in the MBBS program, we also offer a 3-year M.D program giving unique opportunities to expand clinical & research experience, and familiarity with the prevention & treatment of cancers with application of technology, and 3DCRT or intensity-modulated radiotherapy.

Additionally, paramedical courses like B.Sc. Radiotherapy are run to train the students for effective and safe use of radiation.

Through a variety of publications, Radiation Oncology offers news and information on the latest in cancer treatment, research, prevention and education. 

PG Admission Intake: 3 Seats

Eligibility: Admissions to all postgraduate broad-specialty programmes are conducted nationally through the competent authority as prescribed by the Statutory Council (NMC) and as per Government of India Gazette notifications, based on NEET-BS merit.

FACULTY

Dr-Vipul-Nautiyal-Radiotherapy
Dr VIPUL NAUTIYAL
Professor & Head
View Info
Dr-Viney-Kumar
Dr VINEY KUMAR
Associate Professor
View Info
dr-anmol-wadhawa
Dr ANMOL MAHANI
Assistant Professor
View Info
DR-MANSI
Dr MANSI BARTHWAL
Assistant Professor
View Info
Anu Agrawal
Dr ANU AGRAWAL
Assistant Professor
View Info
   Admissions Form         

Admission Open For 2025

×
Professor & Head

Dr Vipul Nautiyal

Qualification: MD Radiation Oncology, MRCP (SCE) Medical Oncology

Teaching & Research Experience: 17 years

Publication: 58 Journal,45 Conference, 1Book chapters

Patent: 2

Area of Interest: Head and neck cancer, breast cancer, genitourinary cancer and palliative care

Membership:

  • Association of Radiation Oncologists of India (AROI)
  • American Society of Clinical Oncology (ASCO)
  • European Society of Medical Oncology (ESMO)
  • UCF (Uttarayan Cancer Foundation)

Awards :

  • AROI Fellowship Award at National AROICON-2017, Lucknow (UP)-went to TMH Mumbai for the same.
  • UICC technical fellowship 2019 at christie School of Oncology, Manchester
  • Best Clinician award 2023.
  • Award for appreciation For Achievement for Cancer Treatment on Doctors Day 1-7-2022 by IMA Uttarakhand.
  • Best Doctor of the year 2024 by Divya Himgiri
  • Health Care Transformation Awards 2024 by Medical Excellence Award
Associate Professor

Dr Viney Kumar

Qualification: MD Radiation Oncology
Ex Clinical Fellow in Rajiv Gandhi Cancer Research Institute, New Delhi
Clinical Oncology by Royal College of Radiologists, NHS

Teaching & Research Experience: 9.5 years

Publication: 23 Journal, 35 Conferences

Patent: 1

Area of Interest: Head and Neck cancer, Genitourinary cancer, Breast cancer, Thoracic cancer, Stereotactic Radiation Therapy (SRT), Stereotactic Body Radiation Therapy (SBRT) and Palliative Care

Membership:

  • Association of Radiation Oncologists of India (AROI)
  • Indian Society of Neuro-Oncology (ISNO)
  • European Society of Medical Oncology (ESMO)
  • American Society of Clinical Oncology (ASCO)
  • UCF (Uttarayan Cancer Foundation)

Awards:

  • Best Oral presentation award: – 2017 Association of Radiation Oncologist of India (AROI), Hisar
  • Best Thesis award: - Study of volumetric and dosimetric changes during fractionated radiotherapy in Head and neck cancers in 2019
  • Best Poster Presentation award: - 2022, AROICON, New Delhi
  • National Builder Award 2024, Rotary Club Dehradun
  • Delhi Ratan 2024, AICOI New Delhi
  • Basic Certificate in Palliative Care, NPTEL Swayam, funded by Govt of India, from Jan-April 2025.
  • Ex- Clinical Fellow in Cyerknife at Rajiv Gandhi Cancer Research Institute, New Delhi
  • UTTARAKHAND RATAN 2025, Intellectual’s foundation (INDIA)
Assistant Professor

Dr Anmol Mahani

Qualification: MD Radiation Oncology (Gold Medallist), MBBS (Gold Medallist)

Teaching & Research Experience: 7 years
Fellowship in Stereotactic Radiotherapy at Tata Memorial Hospital, Mumbai Workshop in Accelerated Partial Breast Radiation at Tokushima University Hospital, Japan

Publication: 24 Publications, 20 conferences, 2 International Conferences, 1 Book chapter

Area of Interest:Breast Oncology, Gynaecological malignancies, Head and neck cancer, Genitourinary cancer, Image-Guided Radiation Therapy (IGRT), Stereotactic Radiation Therapy (SRT), Stereotactic Body Radiation Therapy (SBRT), Brachytherapy and Palliative care

Membership:

  • India Association of Radiation Oncology (AROI)
  • American Society of Clinical Oncology (ASCO)
  • European Society of Medical Oncology (ESMO)
  • American Society of Therapeutic Radiology and Oncology (ASTRO)
  • International Association of Oncology (IAO)
  • Member of The Royal college of Radiologist
  • American Society for Radiation Oncology (ASTRO)
  • Indian Association of Palliative care
  • Pallium
  • UCF (Uttarayan Cancer Foundation)

Awards:

  • Distinction in M.D Radiation Oncology
  • Best Thesis Award in Post-Graduation – Prospective study on location and radiation doses to axillary lymph nodes and its impact on Quality of Life
  • Scored 3rd Price in Poste Presentation in CME and workshop on recent Advances in Breast Cancer Management at Cancer Research Institute, HIMS
  • Gold Medallist in M.B.B.S.
  • Awarded Scholarship of Merit by Army Welfare Association
  • Awarded Best Blog Presetting in the Author’s week Theme Unleashing Open Access potential
  • Certificate of Excellence in Reviewing – Annals of Geriatric Education and Medical Sciences

Assistant Professor

Dr Mansi Barthwal

Qualification: MD Radiation Oncology (KGMU, Lucknow)
Fellowship Advanced Radiation Oncology, CancerCare Manitoba, Canada

Teaching & Research Experience: 10.5 years

Publication: 28 Journal ,23 conference

Area of Interest: Brachytherapy, Stereotactic Radiotherapy, Hemato-lymphoid malignancy (TBI/TMLI), Paediatric Malignancy, , Gynecological Malignancy, GI Malignancy, Neuro-oncology

Membership:

  • AROI (Association of Radiation Oncologists of India)
  • ABS (American Brachytherapy Society)
  • ASTRO (American Society for Radiation Oncology)
  • ESTRO (European Society for Radiotherapy & Oncology)
  • PROS (Paediatric Radiation Oncology Society)
  • SIOP (International Society of Paediatric Oncology)
  • ISNO (Indian Society of Neuro-Oncology)
  • IBS (Indian Brachytherapy Society)
  • ESMO (European Society for Medical Oncology)
  • UCF (Uttarayan Cancer Foundation)

Assistant Professor

Dr Anu Agrawal

Qualification: MD, DNB Radiation Oncology (AIIMS New Delhi)

Teaching & Research Experience: 9 years

Publication: 14, Chapter01

Area of Interest: Head and neck cancer, breast cancer, gynaecological cancer and palliative care

Membership:

  • (ASCO)American Society of Clinical Oncology
  • (AROI)Association of Radiation Oncologists of India
  • (IBS)Indian Brachytherapy Society
  • (ESMO)European Society for Medical Oncology

Awards:

  • Preceptorship in Lung Cancer 2022
  • AROICON 2022 – second position in group discussion

International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.